health pharma news today obesity drugs glp-1 october 2025 Outlook for obesity in 2025: more GLP-1 Pill Helped People With
Description
Seino Y, Yabe D

Are the anti-inflammatory effects of GLP-1 drugs direct or indirect

ESC heart failure

Wegovy is a prescription medication
North America is expected to lead the market, holding a share of 32.3% in 2026